Physician profile
John E Lancaster
NPI 1487622098
$6,377.81
in general payments reported to CMS, 2019-2025
37 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,509 · 2020: $566 · 2021: $560 · 2022: $694 · 2023: $871 · 2024: $966 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,048.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,245.05 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $776.86 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $740.39 | 2021-2025 | |
| Novo Nordisk INC | $524.73 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $486.04 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $439.87 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Amgen INC. | $266.78 | 2019-2025 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $195.19 | 2019-2022 | |
| Glaxosmithkline, LLC. | $191.65 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Abbott Laboratories | $182.89 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $155.15 | 2019-2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Exact Sciences Corporation | $153.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $131.17 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $92.23 | 2020-2021 | |
| Genentech USA, INC. | $89.14 | 2019-2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lancaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.